OPIANT PHARMACEUTICALS INC (OPNT) Stock Analyst Ratings

NASDAQ:OPNT • US6837501039

20.65 USD
-0.12 (-0.58%)
At close: Mar 1, 2023
20.75 USD
+0.1 (+0.48%)
After Hours: 3/1/2023, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to OPNT. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 21.42. This target is 3.73% above the current price.
  • OPNT was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about OPNT.
  • In the previous month the buy percentage consensus was at a similar level.
  • OPNT was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
OPNT Historical Analyst RatingsOPNT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 20.6521.2121.4221.4222.05 - 2.71% 3.73% 3.73% 6.78%

Related screens

Find peers 30% below price target
OPNT Current Analyst RatingOPNT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2021-12-09 Oppenheimer Initiate Outperform

OPIANT PHARMACEUTICALS INC / OPNT FAQ

What is the price target for OPNT stock?

7 analysts have analysed OPNT and the average price target is 21.42 USD. This implies a price increase of 3.73% is expected in the next year compared to the current price of 20.65.


How do analysts rate OPIANT PHARMACEUTICALS INC (OPNT)?

The consensus rating for OPIANT PHARMACEUTICALS INC (OPNT) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts have analysed OPIANT PHARMACEUTICALS INC (OPNT)?

The number of analysts covering OPIANT PHARMACEUTICALS INC (OPNT) is 7.